Precision Medicine | CHOP Research Institute

Precision Medicine

Published on
Oct 11, 2023
The Center for Precision Medicine for High-risk Pediatric Cancer Frontier Program builds upon ongoing precision medicine efforts across CHOP departments to define and expand treatment options.

The Campbell Lab strives to develop approaches to genetic diagnosis so that every child with a genetic disease is diagnosed as quickly and accurately as possible. By harnessing the CHOP electronic health record, the lab uses state-of-the art techniques to define and diagnose genetic diseases.

Providing personalized treatment strategies, using comprehensive multi-omic tumor profiling, to define the best individual treatment options. This includes clinical trials for patients who lack effective standard of care treatments, or who have relapsed or refractory cancers.

Dr. Campbell is interested in approaches to improve diagnosis of children with rare genetic diseases. He also focuses on better understanding of the full spectrum of symptoms associated with genetic diseases as well as discovering new diseases.

campbellim [at]
Published on
Jan 28, 2022
World-class experts will gather at CHOP summit to present on scientific advances in pediatric cancer care in the diagnostics and therapeutic space.

The Helbig Lab uses computational methods to understand the role of clinical and genetic factors in childhood epilepsies, facilitating precision medicine approaches.

Published on
Oct 9, 2020
In the News shares new findings on the treatment of COVID-19 complications, driving license suspensions, lymphatic disorders, and more.
Published on
Feb 7, 2020
The Epilepsy NeuroGenetics Initiative is bridging the gap between advances in genetic discovery and improvements in treatment.
Published on
Dec 20, 2019
A new Frontier Program offers families hope backed by the experience of treating hundreds of cases of congenital hyperinsulinism.
Published on
Jul 3, 2019
Snapshot Science shares a collaborative science success story that helped a preteen with a genetic mutation that disrupted his lymphatic vessels.